What is Anterix Inc's earnings per share (EPS)?

Anterix Inc (ATEX) reported diluted earnings per share of $-0.61 for fiscal year 2025. This represents a -24.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Anterix Inc Financials

ATEX

Source SEC Filings (10-K/10-Q) Updated Feb 11, 2026 Currency USD FYE March

This page shows Anterix Inc (ATEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 37/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Anterix Inc has an operating margin of -194.2%, meaning the company retains $-194 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -241.5% the prior year.

Growth

100

Anterix Inc's revenue surged 43.9% year-over-year to $6.0M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Anterix Inc carries a low D/E ratio of 1.13, meaning only $1.13 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Anterix Inc's current ratio of 2.23 indicates adequate short-term liquidity, earning a score of 41/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Anterix Inc generated -$29.3M in operating cash flow, capex of $87K consumed most of it, leaving -$29.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Anterix Inc generates a -7.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -5.7% the prior year.

Piotroski F-Score Weak

1/9

Anterix Inc passes 1 of 9 financial strength tests. No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality

2.57x

For every $1 of reported earnings, Anterix Inc generates $2.57 in operating cash flow (-$29.3M OCF vs -$11.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.0M

YoY+43.9%

5Y CAGR+31.0%

10Y CAGR+6.6%

Anterix Inc generated $6.0M in revenue in fiscal year 2025. This represents an increase of 43.9% from the prior year.

EBITDA

-$11.2M

YoY-20.3%

Anterix Inc's EBITDA was -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 20.3% from the prior year.

Net Income

-$11.4M

YoY-24.6%

Anterix Inc reported -$11.4M in net income in fiscal year 2025. This represents a decrease of 24.6% from the prior year.

EPS (Diluted)

$-0.61

YoY-24.5%

Anterix Inc earned $-0.61 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 24.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$29.4M

YoY-170.4%

Anterix Inc generated -$29.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 170.4% from the prior year.

Cash & Debt

$47.4M

YoY-21.8%

5Y CAGR-19.2%

10Y CAGR-8.9%

Anterix Inc held $47.4M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

19M

YoY+0.9%

5Y CAGR+1.6%

10Y CAGR+4.0%

Anterix Inc had 19M shares outstanding in fiscal year 2025. This represents an increase of 0.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-194.2%

YoY+47.3pp

5Y CAGR+2205.6pp

10Y CAGR+252.3pp

Anterix Inc's operating margin was -194.2% in fiscal year 2025, reflecting core business profitability. This is up 47.3 percentage points from the prior year.

Net Margin

-188.6%

YoY+29.2pp

5Y CAGR+2218.0pp

10Y CAGR+275.3pp

Anterix Inc's net profit margin was -188.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 29.2 percentage points from the prior year.

Return on Equity

-7.3%

YoY-1.6pp

5Y CAGR+8.1pp

10Y CAGR-0.4pp

Anterix Inc's ROE was -7.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$5.7M

YoY+0.7%

5Y CAGR+14.2%

10Y CAGR+19.1%

Anterix Inc invested $5.7M in research and development in fiscal year 2025. This represents an increase of 0.7% from the prior year.

Share Buybacks

$8.4M

YoY-66.0%

Anterix Inc spent $8.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 66.0% from the prior year.

Capital Expenditures

$87K

YoY-71.7%

5Y CAGR-28.5%

10Y CAGR-34.9%

Anterix Inc invested $87K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 71.7% from the prior year.

ATEX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$6.0M+43.9%	$4.2M+118.4%	$1.9M+77.0%	$1.1M+17.7%	$921K-41.1%	$1.6M
Cost of Revenue	N/A	N/A	$0-100.0%	$5K-99.7%	$1.6M-43.3%	$2.8M
Gross Profit	N/A	N/A	$1.9M+77.8%	$1.1M+257.5%	-$685K+46.0%	-$1.3M
R&D Expenses	$5.7M+0.7%	$5.7M+28.3%	$4.4M+23.5%	$3.6M-17.3%	$4.3M+47.1%	$3.0M
SG&A Expenses	$42.7M-3.9%	$44.4M-1.7%	$45.2M+14.3%	$39.5M+0.6%	$39.3M+54.3%	$25.5M
Operating Income	-$11.7M-15.7%	-$10.1M+38.5%	-$16.5M+55.3%	-$36.8M+32.8%	-$54.8M-46.0%	-$37.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$1.9M+17.3%	$1.6M+27.8%	$1.3M+28.4%	$983K+692.7%	$124K-94.8%	$2.4M
Net Income	-$11.4M-24.6%	-$9.1M+44.1%	-$16.3M+56.5%	-$37.5M+31.1%	-$54.4M-44.6%	-$37.6M
EPS (Diluted)	$-0.61-24.5%	$-0.49+43.7%	$-0.87+58.0%	$-2.07+33.9%	$-3.13-36.7%	$-2.29

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$2K-99.9%	$1.6M+1.4%	$1.6M+9.4%	$1.4M+2.1%	$1.4M-11.3%	$1.6M+1.0%	$1.6M+1.7%	$1.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$1K-99.9%	$1.1M-8.9%	$1.2M+8.2%	$1.1M+2.8%	$1.1M-2.8%	$1.1M-36.9%	$1.8M+1.5%	$1.8M
SG&A Expenses	$9K-99.9%	$8.7M+3.1%	$8.4M-19.6%	$10.4M+13.3%	$9.2M+0.2%	$9.2M-19.3%	$11.4M-11.3%	$12.9M
Operating Income	$9K+100.1%	-$9.1M-114.9%	$60.7M+169.9%	$22.5M+139.3%	$9.4M+33.6%	$7.0M+153.6%	-$13.1M+12.5%	-$15.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$2K+100.1%	-$2.1M-127.3%	$7.5M+433.1%	-$2.3M-434.9%	$674K+388.0%	-$234K-201.7%	$230K-81.2%	$1.2M
Net Income	$7K+100.1%	-$6.6M-112.3%	$53.5M+112.6%	$25.2M+173.5%	$9.2M+19.4%	$7.7M+160.4%	-$12.8M+17.8%	-$15.5M
EPS (Diluted)	$0.35+200.0%	$-0.35-112.2%	$2.86+111.9%	$1.35	N/A	$0.41+159.4%	$-0.69+17.9%	$-0.84

ATEX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$333.1M+2.5%	$324.9M+16.6%	$278.6M+0.2%	$278.0M+9.9%	$253.1M-5.4%	$267.4M
Current Assets	$60.8M-16.8%	$73.0M+22.8%	$59.5M-48.6%	$115.8M-4.4%	$121.0M-14.8%	$142.2M
Cash & Equivalents	$47.4M-21.8%	$60.6M+40.3%	$43.2M-59.1%	$105.6M-10.1%	$117.5M-14.5%	$137.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$0-100.0%	$4K-93.4%	$61K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$176.5M+7.7%	$163.9M+65.9%	$98.8M+7.7%	$91.7M+126.3%	$40.5M+81.6%	$22.3M
Current Liabilities	$27.2M+51.5%	$18.0M-43.7%	$31.9M+231.1%	$9.6M+11.9%	$8.6M-2.4%	$8.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$156.6M-2.8%	$161.0M-10.4%	$179.8M-3.5%	$186.3M-12.3%	$212.5M-13.3%	$245.1M
Retained Earnings	-$391.9M-5.3%	-$372.2M-10.0%	-$338.4M-7.8%	-$313.8M-20.5%	-$260.3M-26.4%	-$205.9M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$417K-99.9%	$417.0M-0.8%	$420.4M+16.9%	$359.6M+7.9%	$333.1M+2.0%	$326.7M+3.0%	$317.2M-1.2%	$321.1M
Current Assets	$50K-99.9%	$50.1M-14.9%	$58.8M+6.2%	$55.4M-8.9%	$60.8M+50.8%	$40.3M-29.1%	$56.8M-13.6%	$65.7M
Cash & Equivalents	$30K-99.9%	$29.5M-24.4%	$39.1M-5.7%	$41.4M-12.5%	$47.4M+64.5%	$28.8M-33.2%	$43.1M-16.6%	$51.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$181K-99.9%	$181.1M+0.6%	$180.0M+3.0%	$174.8M-1.0%	$176.5M-3.0%	$181.9M+2.1%	$178.2M+3.4%	$172.4M
Current Liabilities	$36K-99.9%	$36.0M+4.0%	$34.6M-3.7%	$35.9M+32.2%	$27.2M+11.5%	$24.4M+54.4%	$15.8M-4.3%	$16.5M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$236K-99.9%	$236.0M-1.8%	$240.3M+30.1%	$184.8M+18.0%	$156.6M+8.2%	$144.7M+4.1%	$139.1M-6.5%	$148.8M
Retained Earnings	$321K+100.1%	-$320.8M-2.1%	-$314.2M+14.3%	-$366.8M+6.4%	-$391.9M+1.8%	-$399.2M+0.8%	-$402.5M-3.3%	-$389.7M

ATEX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$29.3M-169.7%	$42.0M+254.1%	-$27.3M-252.1%	$17.9M+279.9%	-$10.0M+64.2%	-$27.8M
Capital Expenditures	$87K-71.7%	$307K-85.6%	$2.1M+101.9%	$1.1M+357.8%	$230K-50.4%	$464K
Free Cash Flow	-$29.4M-170.4%	$41.7M+241.9%	-$29.4M-274.2%	$16.9M+265.5%	-$10.2M+64.0%	-$28.3M
Investing Cash Flow	$22.8M+181.3%	$8.1M+129.8%	-$27.1M+1.0%	-$27.4M-93.4%	-$14.2M-87.5%	-$7.6M
Financing Cash Flow	-$6.6M+73.8%	-$25.1M-211.8%	-$8.1M-233.7%	-$2.4M-157.3%	$4.2M-95.6%	$96.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$8.4M-66.0%	$24.7M+200.1%	$8.2M-45.0%	$15.0M	$0	$0

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$10K+100.1%	-$8.3M-689.2%	$1.4M+144.7%	-$3.1M+81.0%	-$16.6M-115.0%	-$7.7M-190.7%	-$2.6M-12.2%	-$2.4M
Capital Expenditures	$9-99.9%	$9K	N/A	N/A	$46K	$0-100.0%	$41K	$0
Free Cash Flow	$10K+100.1%	-$8.3M	N/A	N/A	-$16.6M-115.6%	-$7.7M-186.3%	-$2.7M-13.9%	-$2.4M
Investing Cash Flow	$6K+100.2%	-$2.3M-281.0%	-$604K+77.3%	-$2.7M-107.5%	$35.4M+2162.6%	-$1.7M+69.0%	-$5.5M-2.7%	-$5.4M
Financing Cash Flow	$2K+115.6%	-$10K+98.9%	-$907K-41.3%	-$642K-143.2%	-$264K+94.6%	-$4.9M-1251.7%	-$362K+66.2%	-$1.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$990	$0-100.0%	$990K	$0-100.0%	$2.0M-55.7%	$4.4M	$0-100.0%	$2.0M

ATEX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	100.0%+0.5pp	99.5%+173.9pp	-74.4%+6.8pp	-81.1%
Operating Margin	-194.2%+47.3pp	-241.5%+616.3pp	-857.8%+2541.5pp	-3399.3%+2551.8pp	-5951.0%-3551.2pp	-2399.8%
Net Margin	-188.6%+29.2pp	-217.8%+632.5pp	-850.3%+2610.9pp	-3461.2%+2449.1pp	-5910.3%-3503.8pp	-2406.5%
Return on Equity	-7.3%-1.6pp	-5.7%+3.4pp	-9.1%+11.1pp	-20.1%+5.5pp	-25.6%-10.3pp	-15.4%
Return on Assets	-3.4%-0.6pp	-2.8%+3.0pp	-5.9%+7.6pp	-13.5%+8.0pp	-21.5%-7.4pp	-14.1%
Current Ratio	2.23-1.8	4.07+2.2	1.86-10.2	12.01-2.0	14.05-2.1	16.11
Debt-to-Equity	1.13+0.1	1.02+0.5	0.55+0.1	0.49+0.3	0.19+0.1	0.09
FCF Margin	-486.7%-1481.3pp	994.7%+2525.5pp	-1530.8%-3086.2pp	1555.3%+2661.7pp	-1106.3%+702.3pp	-1808.6%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	576.0%+1152.1pp	-576.0%-4485.5pp	3909.5%+2324.1pp	1585.4%+908.9pp	676.5%+227.4pp	449.0%+1295.6pp	-846.6%+137.8pp	-984.4%
Net Margin	419.6%+839.3pp	-419.6%-3869.1pp	3449.5%+1673.7pp	1775.7%+1112.8pp	662.9%+170.6pp	492.3%+1315.4pp	-823.1%+194.9pp	-1018.0%
Return on Equity	2.8%+5.6pp	-2.8%-25.1pp	22.3%+8.6pp	13.6%+7.8pp	5.9%+0.5pp	5.3%+14.5pp	-9.2%+1.2pp	-10.4%
Return on Assets	1.6%+3.2pp	-1.6%-14.3pp	12.7%+5.7pp	7.0%+4.2pp	2.8%+0.4pp	2.4%+6.4pp	-4.0%+0.8pp	-4.8%
Current Ratio	1.390.0	1.39-0.3	1.70+0.2	1.54-0.7	2.23+0.6	1.65-1.9	3.59-0.4	3.98
Debt-to-Equity	0.770.0	0.77+0.0	0.75-0.2	0.95-0.2	1.13-0.1	1.26-0.0	1.28+0.1	1.16
FCF Margin	635.7%+1162.1pp	-526.5%	N/A	N/A	-1195.2%-703.6pp	-491.6%-318.3pp	-173.4%-18.6pp	-154.8%

Similar Companies

Wideopenwest WOW

$445.7M

Sify Technologie SIFY

$994.1M

Shenandoah Telecommunications SHEN

$835.1M

Cable One Inc CABO

$548.8M

Altice Usa ATUS

$841.0M

Frequently Asked Questions

What is Anterix Inc's annual revenue?

Anterix Inc (ATEX) reported $6.0M in total revenue for fiscal year 2025. This represents a 43.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Anterix Inc's revenue growing?

Anterix Inc (ATEX) revenue grew by 43.9% year-over-year, from $4.2M to $6.0M in fiscal year 2025.

Is Anterix Inc profitable?

No, Anterix Inc (ATEX) reported a net income of -$11.4M in fiscal year 2025, with a net profit margin of -188.6%.

What is Anterix Inc's EBITDA?

Anterix Inc (ATEX) had EBITDA of -$11.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Anterix Inc's operating margin?

Anterix Inc (ATEX) had an operating margin of -194.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Anterix Inc's net profit margin?

Anterix Inc (ATEX) had a net profit margin of -188.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Anterix Inc's return on equity (ROE)?

Anterix Inc (ATEX) has a return on equity of -7.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Anterix Inc's free cash flow?

Anterix Inc (ATEX) generated -$29.4M in free cash flow during fiscal year 2025. This represents a -170.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Anterix Inc's operating cash flow?

Anterix Inc (ATEX) generated -$29.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Anterix Inc's total assets?

Anterix Inc (ATEX) had $333.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Anterix Inc's capital expenditures?

Anterix Inc (ATEX) invested $87K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Anterix Inc spend on research and development?

Anterix Inc (ATEX) invested $5.7M in research and development during fiscal year 2025.

Does Anterix Inc buy back shares?

Yes, Anterix Inc (ATEX) spent $8.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Anterix Inc have outstanding?

Anterix Inc (ATEX) had 19M shares outstanding as of fiscal year 2025.

What is Anterix Inc's current ratio?

Anterix Inc (ATEX) had a current ratio of 2.23 as of fiscal year 2025, which is generally considered healthy.

What is Anterix Inc's debt-to-equity ratio?

Anterix Inc (ATEX) had a debt-to-equity ratio of 1.13 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Anterix Inc's return on assets (ROA)?

Anterix Inc (ATEX) had a return on assets of -3.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Anterix Inc's cash runway?

Based on fiscal year 2025 data, Anterix Inc (ATEX) had $47.4M in cash against an annual operating cash burn of $29.3M. This gives an estimated cash runway of approximately 19 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Anterix Inc's Piotroski F-Score?

Anterix Inc (ATEX) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Anterix Inc's earnings high quality?

Anterix Inc (ATEX) has an earnings quality ratio of 2.57x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Anterix Inc?

Anterix Inc (ATEX) scores 37 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.